Old Web
English
Sign In
Acemap
>
Paper
>
Abstract LB-202: Phase 1 dose escalation trial of the novel vascular disrupting agent NPI-2358
Abstract LB-202: Phase 1 dose escalation trial of the novel vascular disrupting agent NPI-2358
2008
Monica M. Mita
Matthew A. Spear
Lorrin K. Yee
Kyri Papadopoulos
Elisabeth I. Heath
Ofelia Romero
G. Kenneth Lloyd
Gillian Cropp
Alain C. Mita
Patricia LoRusso
Keywords:
Oncology
dose escalation
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]